Bruker Corporation today announced the launch of the Beacon Discovery ™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop ...

BioNTech SE will showcase data from its oncology pipeline at the AACR Annual Meeting in Chicago from April 25-30, 2025. The presentations will highlight advancements in mRNA cancer immunotherapies, ...

Program chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD, highlight the cross-disciplinary approach to cancer research and innovation being taken at this year's American ...

The American Association for Cancer Research (AACR) Annual Meeting kicks off this week in Chicago. A whirlwind of sessions, keynotes, fireside chats, posters, and exhibitors, the meeting is THE annual ...

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...

CHICAGO – The American Association for Cancer Research (AACR) will honor the following cancer researchers and physician-scientists during the AACR Annual Meeting 2025, to be held April 25-30 at the ...

Ahead of this year’s meeting of the American Association for Cancer Research (AACR), the organization has released the names of the recipients of several professional awards that are given out ...

You’re reading the web edition of AACR in 30 Seconds, STAT’s guide to the American Association for Cancer Research annual meeting. Sign up for email here. AACR’s big annual meeting began as usual with ...

The prize recipients will be recognized on Sunday, April 27, during the Opening Ceremony at the AACR Annual Meeting 2025 in Chicago, Illinois. The AACR Annual Meeting brings together thousands of ...

Leading advances in cancer research, the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics highlighted some of the field’s most promising innovations. Parabilis ...

SENTI-202 and CHS-114 showed promise in treating acute myeloid leukemia and head-and-neck cancers, respectively, by targeting specific cellular mechanisms. An immunomodulatory vaccine advancing to ...

A Compact Benchtop Optofluidic System with Lower Cost of Ownership for Broader Research Accessibility EMERYVILLE, Calif.--(BUSINESS WIRE)-- Bruker Corporation (BRKR) (Nasdaq: BRKR) today announced the ...